By comparison, the foreign trade balance of the pharmaceutical industry is negative in all other Visegrád states (the Czech Republic, Poland, and Slovakia).

Exports of Hungarian pharmaceutical products have developed dynamically, doubling compared to 2002, while domestic sales have remained broadly unchanged.

Despite this, the pharmaceutical sector is also a major player in the domestic economy in terms of revenue, exports and R&D.